GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ryvu Therapeutics SA (WAR:RVU) » Definitions » Price-to-Tangible-Book

Ryvu Therapeutics (WAR:RVU) Price-to-Tangible-Book : 6.42 (As of Sep. 25, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Ryvu Therapeutics Price-to-Tangible-Book?

As of today (2024-09-25), Ryvu Therapeutics's share price is zł55.00. Ryvu Therapeutics's Tangible Book per Share of Jun. 2024 for the quarter that ended in Jun. 2024 was zł8.57. Hence, Ryvu Therapeutics's Price to Tangible Book Ratio of today is 6.42.

The historical rank and industry rank for Ryvu Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

WAR:RVU' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.67   Med: 5.01   Max: 11.67
Current: 6.42

During the past 13 years, Ryvu Therapeutics's highest Price to Tangible Book Ratio was 11.67. The lowest was 2.67. And the median was 5.01.

WAR:RVU's Price-to-Tangible-Book is ranked worse than
77.8% of 1198 companies
in the Biotechnology industry
Industry Median: 2.68 vs WAR:RVU: 6.42

A closely related ratio is called PB Ratio. As of today, Ryvu Therapeutics's share price is zł55.00. Ryvu Therapeutics's Book Value per Sharefor the quarter that ended in Jun. 2024 was zł8.89. Hence, Ryvu Therapeutics's P/B Ratio of today is 6.19.


Ryvu Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Ryvu Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ryvu Therapeutics Price-to-Tangible-Book Chart

Ryvu Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.11 4.20 7.07 2.67 5.25

Ryvu Therapeutics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.67 5.35 5.25 6.76 5.86

Competitive Comparison of Ryvu Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Ryvu Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ryvu Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ryvu Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Ryvu Therapeutics's Price-to-Tangible-Book falls into.



Ryvu Therapeutics Price-to-Tangible-Book Calculation

Ryvu Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2024 )
=55.00/8.568
=6.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Ryvu Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Ryvu Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Ryvu Therapeutics Business Description

Traded in Other Exchanges
Address
Leona Henryka Sternbacha 2, Krakow, POL, 30-394
Ryvu Therapeutics SA is a company which is engaged in discovering and developing small molecule therapies that address oncology. Its product candidate SEL120, is a kinase inhibitor with potential for development in hematological malignancies and solid tumors. The pipeline products of the company are developed in the areas of kinases, cancer metabolism, synthetic lethality, and immuno-oncology pathways.

Ryvu Therapeutics Headlines

No Headlines